Detalles de la búsqueda
1.
Dose of approved COVID-19 vaccines is based on weak evidence: a review of early-phase, dose-finding trials
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22276701
2.
Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of Nsp13 Helicase
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-438808
3.
Age-related heterogeneity in Neutralising antibody responses to SARS-CoV-2 following BNT162b2 vaccination
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21251054
4.
SARS-CoV-2 virus and antibodies in front-line Health Care Workers in an acute hospital in London: preliminary results from a longitudinal study
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20120584
5.
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20120345
6.
Impact of SARS-CoV-2 B.1.1.7 Spike variant on neutralisation potency of sera from individuals vaccinated with Pfizer vaccine BNT162b2
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21249840
7.
Scalable and Resilient SARS-CoV2 testing in an Academic Centre
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20071373
Resultados
1 -
7
de 7
1
Próxima >
>>